Related Experiment Video
Updated: Jun 18, 2026
Multimodality Diagnosis of Mesenteric Ischemia
Published on: July 21, 2023
[Mesenteric fibromatosis]
Helle Lund1, Bettina Filtenborg Ekvall
1Glostrup Hospital, Kirurgisk Afdeling, Denmark. h.lund@dadlnet.dk
Abstract:
Mesenterial fibromatosis is a benign proliferating neoplasia that originates from the mesenterium or retroperitoneum. It occurs spontaneously and in patients with Gardner's syndrome. The only known treatment is resection but recurrence is frequent. We describe a case in a young woman.
Insights
Mesenteric fibromatosis, a benign neoplasia of the mesentery or retroperitoneum, can recur after surgical resection. This summary highlights a case in a young woman, emphasizing challenges in managing this rare condition.
Area of Science:
- Gastroenterology
- Surgical Oncology
- Pathology
Background:
- Mesenteric fibromatosis is a rare, benign neoplastic proliferation originating in the mesentery or retroperitoneum.
- It can arise spontaneously or in association with Gardner's syndrome, a genetic disorder.
- Surgical resection is the primary treatment modality, despite frequent recurrence.
Observation:
- This report details a clinical case of mesenteric fibromatosis in a young female patient.
- The case presentation focuses on the diagnostic and therapeutic challenges encountered.
- Specific clinical and pathological features of this individual case are highlighted.
Findings:
- Mesenteric fibromatosis, though benign, demonstrates a propensity for local recurrence post-resection.
- The spontaneous occurrence and association with Gardner's syndrome underscore its complex etiology.
- Effective long-term management strategies remain an area of clinical interest.
Implications:
- This case contributes to the understanding of mesenteric fibromatosis in a specific demographic.
- It emphasizes the need for vigilant follow-up due to high recurrence rates.
- Further research into novel therapeutic approaches may be warranted for improved patient outcomes.